Orig3n Stock

orig3n.comBioTechFounded: 2014Funding to Date: $85.64MM

Orig3n is a developer of DNA tests designed to help people understand the links between their genes and how their minds and bodies work, and researcher of cellular science to develop personalized therapies for repairing tissue damage and disease.

Register for Details

For more details on financing and valuation for Orig3n, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Robin Smith
Co-Founder & Chief Executive Officer
Kate Blanchard
Co-Founder & Chief Operating Officer
Marcie Glicksman Ph.D
Chief Scientific Officer
Michael Fang MD
Chief Medical Officer

Board Members

Angela Ruggiero
Byron Smith
Mountain Group Partners
Justin Xiang Ph.D
Syno Capital

Other companies like Orig3n in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$197.73MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM